Copenhagens Orbis Medicines is a series a startup. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Orbis Medicines is a biotechnology company utilizing its M platform to discover and develop innovative medicines that tackle diseases caused by protein dysfunction.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky